Comparison of Three Jet Nebulizer Aerosol Delivery Systems Used to Administer Recombinant Human DNase I to Patients With Cystic Fibrosis

Lung Function Testing: Selection of Reference Values and Interpretative Strategies

American Review of Respiratory Disease · 1991 · 2.5K citations

Advanced Lung Disease, Patient Safety, Diagnosis +6

Standardization of Spirometry—1987 Update

American Review of Respiratory Disease · 1987 · 2.3K citations

Pulmonary Care, Pulmonary Circulation, Pulmonary Physiology +5

Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Ronald J. Knudson, M D Lebowitz, Catharine J. Holberg et al. · PubMed · 1983 · 1.9K citations

Asthma, Respiratory Health, Pulmonary Circulation +12

Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis

Henry J. Fuchs, Drucy Borowitz, David Høyrup Christiansen et al. · New England Journal of Medicine · 1994 · 1.5K citations · Full text

Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Steven Shak, Daniel J. Capon, Renate Hellmiss et al. · Proceedings of the National Academy of Sciences · 1990 · 711 citations · Full text

Dna Analysis, Molecular Biology, Nucleic Acid Amplification Test +17